Showing results (3171-3180 of 11,733) with videos related to
Sort By:
Pageof 1,174
European Heart Journal|October 12, 2017
Differential blood pressure effects of ibuprofen, naproxen, and celecoxib in patients with arthritis: the PRECISION-ABPM (Prospective Randomized Evaluation of Celecoxib Integrated Safety Versus Ibuprofen or Naproxen Ambulatory Blood Pressure Measurement) TrialFrank Ruschitzka, Jeffrey S Borer, Henry Krum, et al.European Heart Journal|October 12, 2017
Reappraising myocardial fibrosis in severe aortic stenosis: an invasive and non-invasive study in 133 patientsThomas A Treibel, Begoña López, Arantxa González, et al.European Heart Journal|October 12, 2017
Clinical implications of three-vessel fractional flow reserve measurement in patients with coronary artery diseaseJoo Myung Lee, Bon-Kwon Koo, Eun-Seok Shin, et al.European Heart Journal|October 12, 2017
Impact of design of coronary stents and length of dual antiplatelet therapies on ischaemic and bleeding events: a network meta-analysis of 64 randomized controlled trials and 102 735 patientsFabrizio D'Ascenzo, Mario Iannaccone, Gaelle Saint-Hilary, et al.European Heart Journal|October 12, 2017
Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular modelAshish Mehta, Chrishan J A Ramachandra, Pritpal Singh, et al.European Heart Journal|October 12, 2017
Thrombo-embolic prevention after transcatheter aortic valve implantationPascal Vranckx, Stephan Windecker, Robert C Welsh, et al.European Heart Journal|October 12, 2017
Refining the prognostic impact of functional mitral regurgitation in chronic heart failureGeorg Goliasch, Philipp E Bartko, Noemi Pavo, et al.European Heart Journal|October 12, 2017
Percutaneous short-term active mechanical support devices in cardiogenic shock: a systematic review and collaborative meta-analysis of randomized trialsHolger Thiele, Alexander Jobs, Dagmar M Ouweneel, et al.European Heart Journal|October 12, 2017
Transcatheter aortic valve implantation in lower-risk patients: what is the perspective?Giuseppe Tarantini, Luca Nai Fovino, Bernard J GershEuropean Heart Journal|October 12, 2017
Effects of empagliflozin on risk for cardiovascular death and heart failure hospitalization across the spectrum of heart failure risk in the EMPA-REG OUTCOME® trialDavid Fitchett, Javed Butler, Philippe van de Borne, et al.Pageof 1,174